NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
← Retatrutide vendors

Shandong Aishi BiotechnologyRetatrutide

25 testslatest 23 Sept 2026$0.93/mg median
Free peptide testing

Ordered Retatrutide from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it for free.

Test my supply
+2 more ↓
79%
Finnrick rating
#172 of 378 Retatrutide vendors
20 of 25 classifiable tests passed
customers 4.8★ (18)
methodology · Purity focus
Finnrick analysis · Retatrutide

Shandong Aishi's retatrutide record is mixed: severe earlier misses included 73.18% purity with -95% fill and 96.82% with -72% fill, and the newest lab lot fell to 98.2% purity. Newer passes show recovery but not a fully clean trajectory.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shandong Aishi Biotechnology

Registry records frame Shandong Aishi as a young sole-owner exporter, while TikTok presents a factory-grade production story. The report traces the ownership, claim gaps, DNS/contact stack, and unresolved penalty flags buyers cannot see from the live stats.

21 pages5 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
95%
16
2
Tirzepatide
$0.43
80%
30
3
Retatrutideselected
$0.93
79%
25
4
Ipamorelin
$1.96
75%
4
5
BPC-157
-
55%
3
6
Tesamorelin
$2.10
48%
6
7
HGH
-
38%
3
8
Cagrilintide
$4.40
-
0
9
MOTS-c
-
-
0
10
Semaglutide
$0.65
-
0
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%24 Oct 2025: 75%29 Oct 2025: 76%4 Nov 2025: 78%25 Nov 2025: 79%16 Dec 2025: 81%18 Dec 2025: 82%29 Dec 2025: 79%15 Jan 2026: 80%22 Jan 2026: 81%29 Jan 2026: 83%29 Jan 2026: 79%4 Feb 2026: 80%16 Feb 2026: 81%16 Feb 2026: 78%22 Feb 2026: 79%1 Mar 2026: 80%6 Mar 2026: 81%6 Mar 2026: 81%30 Apr 2026: 83%6 May 2026: 83%8 May 2026: 84%2 Jun 2026: 85%5 Jun 2026: 85%17 Jun 2026: 82%23 Sep 2026: 79%29 Sep 2026: current 79%75%78%79%Oct 25Sep 26
Showing Retatrutide tests only
Free peptide testing

Ordered Retatrutide from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it for free.

Test my supply
Shandong Aishi Biotechnology Retatrutide test history
COA-backed lab tests
1-10 of 25

About Shandong Aishi Biotechnology test results from Finnrick

Shandong Aishi Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 87 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shandong Aishi Biotechnology peptides in this dataset are BPC-157 (3 tests), GHK-Cu (16 tests) and HGH (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 87 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered Retatrutide from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it for free.

Test my supply